4Dx Ltd – First of Its Kind Four-Dimensional X-Ray Lung Imaging

4Dx Limited is a medical technology start-up based in Melbourne, Australia, established to commercialise four-dimensional lung imaging technology: 4DxV.

• Revolutionary diagnostic delivering high resolution, quantitative functional information with low radiation dose as compared to CT and non invasive scanning
• Provides unprecedented levels of detail for the diagnosis and monitoring of debilitating respiratory conditions such as COPD, Cystic Fibrosis, and Asthma.
• Technology that will improve millions of lives through earlier disease detection and more accurate monitoring of chronic respiratory conditions.

Conceived by 4Dx CEO Andreas Fouras and developed by his research group, the Laboratory for Dynamic Imaging at Monash University, this four-dimensional X-ray imaging technology maps the motion and airflow within the breathing lung. This provides information on regional lung function not available in today’s medical clinics.

Initially, its use will be in radiotherapy applications in the fight against cancer. Our four-dimensional X-ray imaging technology will provide invaluable functional information to improve patient outcomes through better treatment planning and monitoring of treatment effectiveness.

The key market for this patented technology will be through the delivery of high-resolution, quantitative function from low dose and non-invasive scanning. Its far reaching potential provides unprecedented levels of detail for the diagnosis and monitoring of debilitating respiratory conditions such as asthma, COPD, cystic fibrosis, and lung cancer.

4Dx is set for an exciting 12 months with the expectation of the publication of major clinical trial results and FDA clearance of its first product. The completion of these major milestones will demonstrate the clinical and commercial value of this technology and positions the company for IPO within the next 24 months.